MSCI, perhaps the most respected provider of investable global indexes, will add five stocks to its All-Country World Index (ACWI), while pulling eight from the broad global equities benchmark as part of its quarterly review of specific constituents.
The three largest additions to the MSCI Global World Index measured by full company market capitalization are U.S.-based Camden Property Trust and Realty Income Corp, and Israel-based Mellanox Technologies, the company said in a press release.
The two additions to the MSCI Emerging Markets Index measured by full company market capitalization are Korea-based Amoreg and Brazil-based Marcopolo, MSCI said.
The changes are likely to be closely followed, given the company’s claim that $7 trillion in assets are benchmarked to its indexes globally. One of the biggest exchange-traded funds using the firm’s indexes is the $54 billion Vanguard MSCI Emerging Markets Index (NYSEArca: VWO).
All the changes, which are now posted on the company’s website, will be implemented on Aug. 31, the company said.
Among some of the various changes that will take place with its various indexes are:
- MSCI Frontier Markets Indices, which will have one addition to and no deletions from the MSCI Frontier Markets Index. The security added to the MSCI Frontier Markets Index is PetroVietnam Gas.
- MSCI Global Small Cap Indices, which will have seven additions and 26 deletions from the MSCI ACWI Small Cap Index.
- MSCI Global Investable Market Indices, which will have no additions and 22 deletions from the MSCI ACWI IMI.
- MSCI Global All Cap Indices: There will be no additions and 22 deletions from the MSCI All Cap Index.
- MSCI Global Islamic Indices: Fifty-one securities will be added and 22 will be deleted from the MSCI ACWI Islamic Index. The three largest additions to the MSCI ACWI Islamic Index are U.S.-based Phillips 66, Intuitive Surgical and Alexion Pharmaceuticals. There are two additions and no deletions from the MSCI Gulf Cooperation Council Countries ex-Saudi Arabia IMI Islamic Index.
It's easy to be blinded by headline numbers. The rally in biotech isn't so simple.
A low-volatility emerging markets ETF outpaces its plain-vanilla counterpart as it marks its three-year anniversary.
It may have been inadvertent, but the SEC’s ruling to block nontransparent active ETFs is a real plus for investors.
Knowing what ‘yield’ even means is a crucial requirement for ETF investors.